Sue-Jean Lin - 09 Jun 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Keith Klein, as Attorney-in-Fact for Sue-Jean Lin
Issuer symbol
ARQT
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 14:07:34 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +25,723 $0.000000 25,723 09 Jun 2021 Common Stock 25,723 $27.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on each of June 9, 2022, June 9, 2023 and June 9, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date.